Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 1
2014 3
2016 2
2017 3
2018 6
2019 5
2020 12
2021 14
2022 15
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
ANGPTL3 Deficiency and Risk of Hepatic Steatosis.
D'Erasmo L, Di Martino M, Neufeld T, Fraum TJ, Kang CJ, Burks KH, Di Costanzo A, Minicocci I, Bini S, Maranghi M, Pigna G, Labbadia G, Zheng J, Fierro D, Montali A, Ceci F, Catalano C, Davidson NO, Lucisano G, Nicolucci A, Arca M, Stitziel NO. D'Erasmo L, et al. Circulation. 2023 Nov 7;148(19):1479-1489. doi: 10.1161/CIRCULATIONAHA.123.065866. Epub 2023 Sep 15. Circulation. 2023. PMID: 37712257
Recent Apolipoprotein CIII trials.
Tramontano D, Bini S, D'Erasmo L, Arca M. Tramontano D, et al. Among authors: d erasmo l. Curr Opin Lipidol. 2022 Dec 1;33(6):309-318. doi: 10.1097/MOL.0000000000000849. Epub 2022 Sep 28. Curr Opin Lipidol. 2022. PMID: 36206093 Review.
New and Emerging Therapies for Dyslipidemia.
Zambon A, Averna M, D'Erasmo L, Arca M, Catapano A. Zambon A, et al. Among authors: d erasmo l. Endocrinol Metab Clin North Am. 2022 Sep;51(3):635-653. doi: 10.1016/j.ecl.2022.02.004. Epub 2022 Jul 10. Endocrinol Metab Clin North Am. 2022. PMID: 35963633 Review.
How ANGPTL3 Inhibition Will Help Our Clinical Practice?
Bini S, Tramontano D, Minicocci I, Di Costanzo A, Tambaro F, D'Erasmo L, Arca M. Bini S, et al. Among authors: d erasmo l. Curr Atheroscler Rep. 2023 Jan;25(1):19-29. doi: 10.1007/s11883-022-01076-w. Epub 2023 Jan 6. Curr Atheroscler Rep. 2023. PMID: 36607583 Review.
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia.
Mulder JWCM, Tromp TR, Al-Khnifsawi M, Blom DJ, Chlebus K, Cuchel M, D'Erasmo L, Gallo A, Hovingh GK, Kim NT, Long J, Raal FJ, Schonck WAM, Soran H, Truong TH, Boersma E, Roeters van Lennep JE; Homozygous Familial Hypercholesterolemia International Clinical Collaborators. Mulder JWCM, et al. Among authors: d erasmo l. JAMA Cardiol. 2024 Apr 1;9(4):313-322. doi: 10.1001/jamacardio.2023.5597. JAMA Cardiol. 2024. PMID: 38353972
ApoCIII: A multifaceted protein in cardiometabolic disease.
D'Erasmo L, Di Costanzo A, Gallo A, Bruckert E, Arca M. D'Erasmo L, et al. Metabolism. 2020 Dec;113:154395. doi: 10.1016/j.metabol.2020.154395. Epub 2020 Oct 12. Metabolism. 2020. PMID: 33058850 Review.
Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries.
Arca M, Celant S, Olimpieri PP, Colatrella A, Tomassini L, D'Erasmo L, Averna M, Zambon A, Catapano AL, Russo P. Arca M, et al. Among authors: d erasmo l. J Am Heart Assoc. 2023 Nov 7;12(21):e026550. doi: 10.1161/JAHA.122.026550. Epub 2023 Oct 18. J Am Heart Assoc. 2023. PMID: 37850449 Free PMC article.
64 results